Bade, Aditya N. http://orcid.org/0000-0003-2511-4461
McMillan, JoEllyn M.
Liu, Yutong
Edagwa, Benson J.
Gendelman, Howard E. http://orcid.org/0000-0002-7831-0370
Funding for this research was provided by:
national institutes of health (P01 DA028555, P01 DA028555-09S1, R01 NS36126, R01 MH121402, P30 MH062261, R01 MH115860, 2R01 NS034239, R01 AI158160, R01AI145542)
bioimaging core (mri) grant from the nebraska center for nanomedicine
Article History
Received: 14 June 2021
Accepted: 25 July 2021
First Online: 14 August 2021
Declarations
:
: All animal studies were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee (IACUC) in accordance with the standards incorporated in the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies, 2011).
: Not applicable.
: Not applicable.
: Drs. Benson Edagwa and Howard E. Gendelman are co-founders of Exavir Therapeutics, Inc., a biotechnology company focused on the development of long-acting antiretroviral medicines. The remaining authors declare that they have no competing interests.